Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1985 Sep;61(3):633–641.

Expansion of a minor subpopulation of peripheral blood lymphocytes (T8+/Leu 7+) in patients with haemophilia

H W L Ziegler-Heitbrock, W Schramm, D Stachel, H Rumpold, D Kraft, D Wernicke, K Von Der Helm, J Eberle, F Deinhardt, E P Rieber, G Riethmüller
PMCID: PMC1577282  PMID: 4075588

Abstract

Immunological analysis of peripheral blood mononuclear cells (PBM) was performed in 20 patients with haemophilia A or B. One of the patients had never received clotting factor substitution in his life. Six different sources of lyophilized clotting factor were used for the other patients, but every given patient received factor from one source, exclusively. None of the patients exhibited lymphadenopathy and only one suffered from local bacterial infection. Mononuclear cell counts were within the normal range and mitogen stimulation with phythaemagglutinin (PHA) and concanavalin A (Con A) was found normal in all but two patients. Ratios of helper and suppressor cells (T4/T8) were below 1·0 in 10 of the patients. Some of these patients had a relative increase of T8+ cells and at the same time of Leu 7+ (natural killer (NK)/suppressor) cells. Double-marker analysis revealed that the subpopulation of cells expressing both the T8 and the Leu 7 antigen, which on the average accounted for 2·1% of the mononuclear cells in controls, was increased 4·5 fold (9·1%) in haemophilia patients. One patient exhibited 37·8% T8+/Leu 7+ double-marker cells. VEP13+ cells (active NK cells) were decreased below the normal range in 11 of the patients. Abnormal values for lymphocyte subsets were found in every treatment group. The patient who had never received any clotting factor exhibited normal values in all respects.

In an additional set of patients, those with increased percentage of T8+/Leu 7+ cells exhibited decreased NK cell activity indicating that the T8+/Leu 7+ cells are not active NK cells. The expanded subpopulations of T8+/Leu 7+ double-marker cells described in this report might represent an important immunoregulatory subset, and deserves further study in patients with immunodeficiency.

Seropositivity for human T-cell leukaemia virus (HTLV-III) was detected in six of 18 sera tested. The presence of antibody, however, did not correlate with any of the immunological abnormalities, including the expanded T8+/Leu 7+ double-marker cells.

Full text

PDF
633

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981 Sep;127(3):1024–1029. [PubMed] [Google Scholar]
  2. Abo T., Miller C. A., Gartland G. L., Balch C. M. Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J Exp Med. 1983 Jan 1;157(1):273–284. doi: 10.1084/jem.157.1.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Born M., von der Helm K., Wernicke D., Deinhardt F. Presence of antibodies to human lymphoma-leukemia virus (HTLV-I) in Germans with symptoms of the acquired immunodeficiency syndrome (AIDS). J Med Virol. 1985 Jan;15(1):57–63. doi: 10.1002/jmv.1890150108. [DOI] [PubMed] [Google Scholar]
  4. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984 May 4;224(4648):500–503. doi: 10.1126/science.6200936. [DOI] [PubMed] [Google Scholar]
  5. Goldsmith J. C., Moseley P. L., Monick M., Brady M., Hunninghake G. W. T-lymphocyte subpopulation abnormalities in apparently healthy patients with hemophilia. Ann Intern Med. 1983 Mar;98(3):294–296. doi: 10.7326/0003-4819-98-3-294. [DOI] [PubMed] [Google Scholar]
  6. Groopman J. E. Causation of AIDS revealed. 1984 Apr 26-May 2Nature. 308(5962):769–769. doi: 10.1038/308769a0. [DOI] [PubMed] [Google Scholar]
  7. Huwyler T., Morell A., Hirt A., Ricci C., Wagner H. P., Barandun S. Correlation of natural killer cell function with Leu 7 reactivity in patients with humoral immunodeficiency. Clin Exp Immunol. 1984 Jun;56(3):486–492. [PMC free article] [PubMed] [Google Scholar]
  8. Jett J. R., Kuritsky J. N., Katzmann J. A., Homburger H. A. Acquired immunodeficiency syndrome associated with blood-product transfusions. Ann Intern Med. 1983 Nov;99(5):621–624. doi: 10.7326/0003-4819-99-5-621. [DOI] [PubMed] [Google Scholar]
  9. Kaplan J., Sarnaik S., Gitlin J., Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood. 1984 Jul;64(1):308–310. [PubMed] [Google Scholar]
  10. Lechner K., Niessner H., Bettelheim P., Deutsch E., Fasching I., Fuhrmann M., Hinterberger W., Korninger C., Neumann E., Liszka K. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates. Thromb Haemost. 1983 Aug 30;50(2):552–556. [PubMed] [Google Scholar]
  11. Lederman M. M., Ratnoff O. D., Scillian J. J., Jones P. K., Schacter B. Impaired cell-mediated immunity in patients with classic hemophilia. N Engl J Med. 1983 Jan 13;308(2):79–83. doi: 10.1056/NEJM198301133080205. [DOI] [PubMed] [Google Scholar]
  12. Lifson J. D., Benike C. J., Mark D. F., Koths K., Engleman E. G. Human recombinant interleukin-2 partly reconstitutes deficient in-vitro immune responses of lymphocytes from patients with AIDS. Lancet. 1984 Mar 31;1(8379):698–702. doi: 10.1016/s0140-6736(84)92220-7. [DOI] [PubMed] [Google Scholar]
  13. Lohmeyer J., Rieber P., Feucht H., Johnson J., Hadam M., Riethmüller G. A subset of human cells isolated and characterized by monoclonal antibodies. Eur J Immunol. 1981 Dec;11(12):997–1001. doi: 10.1002/eji.1830111209. [DOI] [PubMed] [Google Scholar]
  14. Luban N. L., Kelleher J. F., Jr, Reaman G. H. Altered distribution of T-lymphocyte subpopulations in children and adolescents with haemophilia. Lancet. 1983 Mar 5;1(8323):503–505. doi: 10.1016/s0140-6736(83)92193-1. [DOI] [PubMed] [Google Scholar]
  15. Maccario R., Ugazio A. G., Nespoli L., Alberini C., Montagna D., Porta F., Bonetti F., Burgio G. R. Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells. Clin Exp Immunol. 1984 Jul;57(1):220–226. [PMC free article] [PubMed] [Google Scholar]
  16. Menitove J. E., Aster R. H., Casper J. T., Lauer S. J., Gottschall J. L., Williams J. E., Gill J. C., Wheeler D. V., Piaskowski V., Kirchner P. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med. 1983 Jan 13;308(2):83–86. doi: 10.1056/NEJM198301133080206. [DOI] [PubMed] [Google Scholar]
  17. Perussia B., Starr S., Abraham S., Fanning V., Trinchieri G. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J Immunol. 1983 May;130(5):2133–2141. [PubMed] [Google Scholar]
  18. Perussia B., Trinchieri G., Jackson A., Warner N. L., Faust J., Rumpold H., Kraft D., Lanier L. L. The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol. 1984 Jul;133(1):180–189. [PubMed] [Google Scholar]
  19. Pinching A. J. The acquired immune deficiency syndrome. Clin Exp Immunol. 1984 Apr;56(1):1–13. [PMC free article] [PubMed] [Google Scholar]
  20. San Miguel J. F., Vicente V., González M., Caballero M. D., Rodriguez C., Alberca I., López Borrasca A. T cells subpopulations in untreated and treated patients with haemophilia A and B. Blut. 1983 Nov;47(5):311–313. doi: 10.1007/BF00319901. [DOI] [PubMed] [Google Scholar]
  21. Tilden A. B., Abo T., Balch C. M. Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody. J Immunol. 1983 Mar;130(3):1171–1175. [PubMed] [Google Scholar]
  22. Vilmer E., Barre-Sinoussi F., Rouzioux C., Gazengel C., Brun F. V., Dauguet C., Fischer A., Manigne P., Chermann J. C., Griscelli C. Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet. 1984 Apr 7;1(8380):753–757. doi: 10.1016/s0140-6736(84)91275-3. [DOI] [PubMed] [Google Scholar]
  23. Ziegler-Heitbrock H. W., Rumpold H., Kraft D., Wagenpfeil C., Munker R., Abo T., Balch C. M., LeBien T. W. Patients with a deficiency of natural killer cell activity lack the VEP13-positive lymphocyte subpopulation. Blood. 1985 Jan;65(1):65–70. [PubMed] [Google Scholar]
  24. von der Helm K., Duesberg P. H. Translation of Rous sarcoma virus RNA in a cell-free system from ascites Krebs II cells. Proc Natl Acad Sci U S A. 1975 Feb;72(2):614–618. doi: 10.1073/pnas.72.2.614. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES